1-888-PLEXUS0 (753-9870)
info@plexusventures.com
December 28, 2009
Plexus Ventures Makes Holiday Donation; Mailing List Selects Recipient
December 26, 2009
California Biotechs Have Essential Ingredients for Success; Attract Investment from Japanese Firms
November 24, 2009
Can Fite BioPharma retains Plexus Ventures to Partner their Phase II Lead Compound, Developed for Psoriasis and Other Indications
September 9, 2009
EUSA retains Plexus Ventures to manage the divestment of global rights to ProstaScint®
December 31, 1969
FDA OKs wider use of AstraZeneca’s Crestor
December 31, 1969
Novartis buys rights to Debiopharm's hep C drug
December 31, 1969
Cost-cutting and emerging markets key for Europe's drugmakers
December 31, 1969
Study to look at earlier use of MS drug Tysabri
December 31, 1969
Alzheimer's drug Dimebon may help Huntington's patients
Overview
Our Approach
Our History
Our Team
Our Offices
Overview
In-Licensing
Out-Licensing
Acquisitions
Divestments
Overview
Case Studies
Client List
Press Releases
Articles & Presentations
Media Inquiries